Skip to content

The regulatory functions of imbalance of gut microbiota in coronary artery lesions in Kawasaki disease

The regulatory functions of imbalance of gut microbiota in coronary artery lesions in Kawasaki disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063102
Enrollment
Unknown
Registered
2022-08-30
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

Sponsors

Xuzhou Children's Hospital, Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Years

Inclusion criteria

Inclusion criteria: 1. Children with a clinical diagnosis of Kawasaki disease, the diagnostic criteria need to be in accordance with the 2017 American Heart Association (AHA) statement on the Diagnosis Treatment and Long-Term Follow-up of Kawasaki Disease; 2. Within 10 days of onset (with fever onset as the onset); 3. Aged 1 month to 12 years.

Exclusion criteria

Exclusion criteria: 1. Use of hormones or other immunosuppressants within 1 month before onset of disease; 2. Definite infections, including sepsis, bacterial pneumonia, bacterial meningitis, acute peritonitis, etc.; 3. Severe immune diseases such as immune deficiency or chromosome abnormality; 4. Unwilling to sign informed consent; 5. Regular follow-up cannot exceed 1 year as required.

Design outcomes

Primary

MeasureTime frame
gut microbiota;

Countries

China

Contacts

Public ContactWang Fei
xzwfei@hotmail.com+86 15895227879

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026